Adient price target lowered to $24 from $29 at Stifel

Stifel analyst Nathan Jones lowered the firm’s price target on Adient (ADNT) to $24 from $29 and keeps a Buy rating on the shares after the company reported fiscal Q4 results and provided guidance for FY26 with consensus revenue in line but EBITDA materially below expectations. The firm thinks management has built in “a relatively negative scenario” in terms of production disruptions from recent customer supply chain issues, which could potentially be revised upwards should production catch up in calendar 2026, the analyst tells investors.